PALO ALTO, Calif.--(BUSINESS WIRE)--April 7, 2006--Connetics Corporation (NASDAQ:CNCT - News), a specialty pharmaceutical company that develops and commercializes dermatology products, today provided new information regarding Securities and Exchange Commission (SEC) matters.
